What is the standard procedure for pharmacokinetic (PK) sample collection in a patient with a peripheral intravenous (IV) line, receiving an oral drug, with sample collection timepoints at 0, 30, 60, 120, and 180 minutes post-dose, and flushed with saline without continuous fluid infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Standard Procedure for PK Sample Collection from Peripheral IV Line

When collecting PK samples from a peripheral IV line used for saline flushing only (not continuous infusion), you must discard an adequate volume of blood before collecting the actual sample to prevent dilution from residual flush solution.

Core Sampling Protocol

Pre-Collection Requirements

  • Record precise timing: Document the exact time of oral drug administration and each sample collection using calendar time (month, day, hours, minutes) to ensure accurate PK modeling 1, 2

  • Obtain baseline sample: Collect a pre-dose sample (time 0) before drug administration to establish baseline levels 1, 2

  • Document recent dosing history: Record the times and doses of any recent prior doses of the same medication 1

Critical IV Line Sampling Technique

The key procedural step when sampling from a peripheral IV line that is flushed with saline:

  • Discard volume first: Before collecting each PK sample, withdraw and discard 3-5 mL of blood (or at least 2-3 times the dead space volume of the catheter and extension tubing) to clear any residual saline flush that could dilute your sample

  • Then collect the actual sample: After discarding the initial volume, collect your PK sample in the appropriate tube

  • Flush after collection: After obtaining the sample, flush the line again with saline to maintain patency for the next timepoint

Sample Collection Timepoints

  • Your specified timepoints (0,30,60,120,180 minutes) are appropriate for capturing early absorption and distribution phases of an oral drug 1

  • Record actual collection times: Document the precise time each sample is actually collected, not just the scheduled time, as delays can significantly affect PK analysis 1, 2

Laboratory Handling

  • Use appropriate assay methods: Ensure the laboratory uses validated analytical methods suitable for your specific drug 1

  • Report all measurements: Include any values below the limit of quantification (BLQ) rather than discarding them, as this data is valuable for PK modeling 1, 3

  • Standardize units: Report concentrations in consistent units (e.g., ng/mL or μg/mL) 1

Common Pitfalls to Avoid

  • Inadequate discard volume: Failing to discard sufficient blood before sample collection is the most critical error when using an IV line for PK sampling, as residual saline will falsely lower measured drug concentrations

  • Imprecise timing documentation: Recording only approximate times rather than exact times compromises the accuracy of PK parameter estimation 1, 2

  • Sampling from the same line used for drug infusion: While not applicable to your oral drug scenario, never sample from a line used to administer IV medication without adequate discard volume and time separation

  • Discarding BLQ values: Laboratories may report concentrations as "undetectable" or "<LLOQ" - these should be recorded as reported, not excluded from analysis 1, 3

Additional Documentation

  • Record relevant covariates: Document patient height, weight, and any factors that might affect drug disposition 1

  • Note clinical status: Perform sampling under stable, non-acute conditions when possible for more reliable PK assessment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pharmacokinetics of Bispecific Antibodies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

PK Sample Collection in Control Groups for GLP Studies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.